Understanding the Hexagonal Phase Phospholipid Biomarker
The Hexagonal Phase Phospholipid test is a specialized assay used to detect lupus anticoagulants (LA), a type of autoantibody associated with an increased risk of blood clots and antiphospholipid syndrome (APS). This test assesses the phospholipid dependency of clotting, utilizing a specific phase of phospholipids that increases test sensitivity for lupus anticoagulants.
How It Works
Phospholipids in a hexagonal phase have a unique arrangement that makes them effective in identifying lupus anticoagulants. These autoantibodies target phospholipid-binding proteins, disrupting normal blood clotting processes. By using this specific phase of phospholipids, the test can more accurately confirm or exclude the presence of LA.
Clinical Implications
- Positive Result: Indicates the presence of lupus anticoagulants, suggesting a higher risk of thrombosis or complications like recurrent miscarriages.
- Negative Result: Typically rules out LA as a factor in clotting abnormalities.
Why is This Test Important?
The Hexagonal Phase Phospholipid test is often used alongside other lupus anticoagulant tests (like dRVVT and aPTT) to provide a comprehensive assessment of clotting abnormalities. It is especially critical in diagnosing APS and guiding treatment decisions to manage clotting risks effectively.
Patients with abnormal results should discuss their implications with a healthcare provider to understand the potential risks and next steps for management or additional testing.
Hexagonal Phase Phospholipid
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.